This website uses cookies. For more information please contact us or consult our privacy policy.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- Pharma and Biotech In Licensing and Collaboration Agreements A Deal Lawyers Guide to EU Anti Trust Pitfalls
Pharma and Biotech In-Licensing and Collaboration Agreements: A Deal Lawyer's Guide to EU Anti-Trust Pitfalls
2006/2007, PLC Cross-border Life Sciences Handbook
Covington Announces Three New Special Counsel
August 11, 2013
WASHINGTON, DC, August 12, 2013 — Covington & Burling is pleased to announce the promotion of three lawyers to special counsel, effective August 1, 2013. Michael Clancy (Brussels) focuses his practice on EU competition law, and has extensive experience advising clients in regulated industries such as life sciences (pharmaceuticals, biotech, and medical devices) ...
Covington Advises Encysive on Pfizer Deal
2/21/2008
WASHINGTON, DC, February 21, 2008 — Encysive Pharmaceuticals Inc. announced yesterday that it has entered into an agreement to be acquired by Pfizer Inc. Under the terms of the agreement, Pfizer will make a cash tender offer for all issued and outstanding shares of Encysive for $2.35 per share, representing an equity value of approximately $195 million. ...
Covington Advises Procter & Gamble in Consumer Diagnostic Products Joint Venture with Inverness
May 18, 2007
NEW YORK, NY, May 18, 2007 — The Procter & Gamble Company and Inverness Medical Innovations, Inc. announced that they have completed their previously announced deal to form a 50/50 joint venture for the development, manufacturing, marketing and sale of existing and to-be-developed consumer diagnostic products. Inverness contributed its related consumer ...